Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imotun in Osteoarthritis of the Knee
NCT01743287Phase 4Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Dec 2012
- Primary completion
- Apr 2015
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Imotun capsule placebo in knee osteoarthritis (OA) (2 arms), sponsored by Chong Kun Dang Holdings. Primary endpoints: 100mm Pain Visual Analog Scale at 24 weeks and Change from baseline Lequesne's index score at 24 weeks. Started Dec 2012; status: completed.
02
Drugs
Imotun capsule placebo
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01743287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743287.